Nathan Parkin has been reshaping the $13 billion money manager’s portfolio since taking the job in July, topping up on ASX ...

Following recent weakness, should you buy the dip on CSL Ltd (ASX: CSL) shares today amid the company's push for long-term ...

Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months ...

The NSW Supreme Court has ruled in favour of Mayne Pharma, in a stoush over suitor Cosette's now-reluctant $670 million takeover offer.

CSL Behring Canada Inc., a business unit of global biopharma leader CSL, today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public ...

The United States will impose a 100 per cent tariff on imports of branded or patented pharmaceutical products from October 1, ...

Morningstar Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar ...

The chief executives of some of Victoria’s largest publicly listed companies earned more than $13m each in the most recent ...

Another Australian stock to buy and hold with the $5,000 is Goodman Group. It is a global industrial property developer and manager with a focus on logistics and data centres. Its developments are in ...

Health Minister Mark Butler says Australia’s Pharmaceutical Benefits Scheme will be protected at all costs, despite a pending ...

Let's see why these highly rated ETFs could be great long term picks. The post 3 strong ASX ETFs to buy and hold for a decade or more appeared first on The Motley Fool Australia.

Brokers think investors should buy these shares while they are down in the dumps. The post 3 rock-bottom ASX stocks to grab with $3,000 appeared first on The Motley Fool Australia.